welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Guidelines for the Clinical Management of Familial Adenomatous Polyposis
source: Gut Journal
year: 2008
authors: Vasen H F, Möslein G, Alonso A, Aretz V, Bertario V, Blanco I, Bernstein I, Bülow V, Capella G, Colas C, Engel C, Frayling I, Friedl W, Hes F J, Hodgson S, Järvinen H, Mecklin J P, Møller P, Myrhøi T, Nagengast F M, Parc Y, Phillips R, Clark S K, de Leon MP, Renkonen-Sinisalo L, Sampson J R, Stormorken A, Tejpar S, Thomas H J, Wijnen J
summary/abstract:Familial adenomatous polyposis (FAP) is a well-described inherited syndrome, which is responsible for <1% of all colorectal cancer (CRC) cases. The syndrome is characterised by the development of hundreds to thousands of adenomas in the colorectum. Almost all patients will develop CRC if they are not identified and treated at an early stage. The syndrome is inherited as an autosomal dominant trait and caused by mutations in the APC gene. Recently, a second gene has been identified that also gives rise to colonic adenomatous polyposis, although the phenotype is less severe than typical FAP. The gene is the MUTYH gene and the inheritance is autosomal recessive. In April 2006 and February 2007, a workshop was organised in Mallorca by European experts on hereditary gastrointestinal cancer aiming to establish guidelines for the clinical management of FAP and to initiate collaborative studies. Thirty-one experts from nine European countries participated in these workshops. Prior to the meeting, various participants examined the most important management issues according to the latest publications. A systematic literature search using Pubmed and reference lists of retrieved articles, and manual searches of relevant articles, was performed. During the workshop, all recommendations were discussed in detail. Because most of the studies that form the basis for the recommendations were descriptive and/or retrospective in nature, many of them were based on expert opinion. The guidelines described herein may be helpful in the appropriate management of FAP families. In order to improve the care of these families further, prospective controlled studies should be undertaken.
organization: Leiden University Medical CentreDOI: 10.1136/gut.2007.136127
read more full text source
expertly curated content related to this topic
-
How often should patients with familial colorectal cancer risk be screened?Medical Research: What is the background...
-
How to Care for Your Stoma After an OstomyThe days that follow your colostomy proc...
-
Thetis Pharmaceuticals Awarded Key Patent on HEALER TechnologyThetis Pharmaceuticals LLC, a privately-...
-
Familial Adenomatous Polyposis: Ileo-Anal Pouch versus Ileo-Rectal AnastomosisAIM : In this study we describe the pres...
-
A Randomized Placebo-Controlled Prevention Trial of Aspirin and/or Resistant Starch in Young People with Familial Ad...Evidence supporting aspirin and resistan...
-
Endoscopic Management of Familial Adenomatous Polyposis in Patients Refusing ColectomyBACKGROUND AND STUDY AIMS : Colectomy pr...
-
Familial Colon Cancer Syndromes: An Update of a Rapidly Evolving FieldColorectal cancer (CRC) is a major cause...
English
Portuguese
Spanish